Company continuing to advance ATRC-101, ATRC-301 and other oncology pipeline assets
Extends cash runway through 2023 and reduces workforce by more than 25%
Read more at globenewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Company continuing to advance ATRC-101, ATRC-301 and other oncology pipeline assets
Extends cash runway through 2023 and reduces workforce by more than 25%
Read more at globenewswire.com